4//SEC Filing
Berger Mark Stanley 4
Accession 0001213900-18-009320
CIK 0001388320other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:15 PM ET
Size
5.4 KB
Accession
0001213900-18-009320
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Award
Options to purchase common stock
2018-07-13$0.78/sh+250,000$195,725→ 250,000 totalExercise: $0.78From: 2018-07-13Exp: 2028-07-13→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001700283
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:15 PM ET
- Size
- 5.4 KB